Virtu Financial’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-20,899
Closed -$149K 2011
2024
Q2
$149K Buy
+20,899
New +$160K 0.01% 774
2020
Q3
Sell
-10,055
Closed -$66K 1618
2020
Q2
$66K Buy
+10,055
New +$56.1K 0.01% 964
2019
Q4
$128K Sell
16,685
-4,683
-22% -$27.3K 0.01% 1035
2019
Q3
$113K Sell
21,368
-25,938
-55% -$161K 0.01% 1067
2019
Q2
$264K Buy
+47,306
New +$195K 0.02% 860
2019
Q1
Sell
-17,402
Closed -$71K 1944
2018
Q4
$71K Buy
+17,402
New +$90.8K ﹤0.01% 1216
2018
Q2
Sell
-49,392
Closed -$144K 2594
2018
Q1
$144K Buy
49,392
+29,759
+152% +$91.9K 0.01% 1479
2017
Q4
$76K Buy
+19,633
New +$84.1K ﹤0.01% 1988

Other funds holding CDMO

Virtu Financial's CDMO Position: Q3 2024 in Review

Virtu Financial sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2024, closing a stake of 20,899 shares — an estimated $149K sold.

Virtu Financial first reported a position in CDMO in Q4 2017 and held it in 8 quarters. The position peaked at $264K in Q2 2019. 171 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

  • Virtu Financial reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Virtu Financial sold 20,899 Avid Bioservices, Inc. Common Stock shares in Q3 2024, an estimated $149K.
  • Virtu Financial first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
  • Virtu Financial's Avid Bioservices, Inc. Common Stock position peaked at $264K in Q2 2019.
  • 171 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.